Access Pharmaceuticals Signs US License Agreement With AMAG Pharmaceuticals...
DALLAS and NEW YORK, June 10, 2013 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, today announced that it had entered into an exclusive license...
View ArticleEcho Therapeutics Submits Pre-Submission Package to FDA for Symphony® CGM...
Tweet Send to a Friend Get Alerts ECTE Hot Sheet Price: $5.35 -78.51% Overall Analyst Rating: BUY ( Up) EPS Growth %: -62.5% Trade ECTE Now! PHILADELPHIA, June 10, 2013 /PRNewswire/ -- Echo...
View ArticleAstraZeneca to acquire Pearl Therapeutics to strengthen respiratory...
(Source: AstraZeneca plc) AstraZeneca announced today that it has entered into a definitive agreement to acquire Pearl Therapeutics, a privately held company based in Redwood City, California, focused...
View ArticlePearl Therapeutics to be Acquired by AstraZeneca for up to $1.15 Billion
Tweet Send to a Friend Redwood City, CA, June 10, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that it has entered into a definitive merger agreement under which the Company will...
View ArticleBiotech company DePinho co-founded slashing jobs, restructuring
Dr. Ronald DePInho is the President of M.D. Anderson and co-founder of Aveo Pharmaceuticals. Reporter- Houston Business Journal | | A biotechnology company the University of Texas M.D. Anderson Cancer...
View ArticleEcho Therapeutics (ECTE) Files Pre-Submission with FDA for Symphony CGM System
Tweet Send to a Friend Get Alerts ECTE Hot Sheet Price: $5.35 -78.51% Overall Analyst Rating: BUY ( Up) Revenue Growth %: -100.0% Trade ECTE Now! Echo Therapeutics, Inc. (Nasdaq: ECTE) has...
View ArticleMcDonald's (MCD) Comps up 2.6% in May; Est. at 1.9%
Tweet Send to a Friend Get Alerts MCD Hot Sheet Price: $98.28 --0% Overall Analyst Rating: NEUTRAL (= Flat) Dividend Yield: 3.2% Revenue Growth %: +9.5% Trade MCD Now! McDonald's Corp (NYSE: MCD)...
View ArticleAMAG Pharmaceuticals Obtains US Commercial Rights to MuGard(TM) A...
(Source: AMAG Pharmaceuticals Inc) AMAG Pharmaceuticals Obtains US Commercial Rights to MuGard(TM) A Prescription Oral Rinse to Manage Oral Mucositis Expands AMAG's Product Offerings for...
View ArticleAMAG Pharmaceuticals Obtains US Commercial Rights to MuGard(TM) A...
LEXINGTON, Mass., June 10, 2013 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) announced today that it has licensed the US commercial rights to MuGard™, a marketed product for the...
View ArticleAMAG Pharmaceuticals Announces Submission of a Type II Variation for Rienso...
(Source: AMAG Pharmaceuticals Inc) AMAG Pharmaceuticals Announces Submission of a Type II Variation for Rienso Label Expansion in Europe to Include All Adult Iron Deficiency Anemia Patients Who Cannot...
View ArticleAMAG Pharmaceuticals Announces Submission of a Type II Variation for Rienso...
LEXINGTON, Mass., June 7, 2013 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (AMAG) today announced that its European commercial partner, Takeda Pharmaceutical Company Limited, has submitted a...
View ArticleComcast to expand number of neighborhood Wi-Fi hotspots
Story Highlights Comcast's neighborhood Wi-Fi hotspots are available to about 100,000 customers Comcast said Monday that it will install more neighborhood Wi-Fi hotspots in its service markets to...
View ArticleAMAG Pharmaceuticals Announces Submission of a Type II Variation for Rienso...
LEXINGTON, Mass., June 7, 2013 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that its European commercial partner, Takeda Pharmaceutical Company Limited, has submitted a...
View ArticleComcast plans millions of WiFi hot spots
Travel Deals $77 & up -- Atlantic City Boardwalk Hotel w/$20 Credit See all travel deals » Bob Fernandez, Inquirer Staff Writer Posted: Monday, June 10, 2013, 3:01 AM Comcast Corp. says it will...
View ArticleFDA rejects Aveo kidney cancer drug, asks for additional trial
(Reuters) - Aveo Oncology said the Food and Drug Administration denied...
View ArticleExact Sciences (EXAS) Submits PMA to FDA for Cologuard
Tweet Send to a Friend Get Alerts EXAS Hot Sheet Price: $12.91 --0% Overall Analyst Rating: BUY ( Up) EPS Growth %: +10.5% Trade EXAS Now! Exact Sciences Corp (Nasdaq: EXAS) has submitted to the U.S....
View ArticleNCTA13: Comcast Launches Neighborhood Wi-Fi Hotspots From Customers' Homes
0 0 0 0 0 Email Print Comments Tim Boyle/Getty Images The nation’s largest broadband provider said the initiative is part of a strategy to allow customers "to connect all devices, anywhere and at any...
View ArticleCableWiFi Alliance Offers Access to More Than 150,000 WiFi Hotspots, Creates...
Cablevision, Comcast, Time Warner Cable, Cox Communications and Bright House Networks today announced their combined WiFi network has exceeded more than 150,000 hotspots in major cities across the...
View ArticleImmunoCellular Therapeutics Announces Recommendation of Data Monitoring...
Study Completion Anticipated by Year-End 2013 LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) announced that the Data Monitoring Committee (DMC) has...
View ArticleImmunoCellular Therapeutics Announces Recommendation of Data Monitoring...
ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) announced that the Data Monitoring Committee (DMC) has completed a pre-specified interim analysis of the ICT-107 phase II clinical...
View Article
More Pages to Explore .....